NCT Number: NCT02070328
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
Proton therapy is a limited medical resource that is more expensive than conventional x-ray therapy. To correctly measure the success of proton therapy in treating different conditions, it is important to check a patient's health status after their treatment is finished. Checking on the progress of patients over many years (called long-term follow-up) is needed because the long-term effects of proton therapy are not well known.
Interested in participating?
Request InfoKey information
About this study
The objective of this research protocol is the development of a national Proton Therapy Center Registry for the purpose of:
- Performing retrospective research studies on diseases treated with proton therapy throughout the United States.
- Maintaining regular, lifetime contact with subjects in order to obtain current identification , contact information, and self/parent-reported health status in order to obtain a better understanding of overall treatment strategies and patient benefits of treatment.
- Permitting review of medical record information contained within the Registry to identify subjects who may be eligible for participation in future research studies conducted at the Proton Therapy Institution where the participant was treated. Obtaining the permission of Research Registry participants to be contacted to ascertain their interest in participating in future research studies being conducted at their participating Proton Therapy Institution for which it appears (i.e., based on medical information contained within the Research Registry) they may be eligible.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All subjects who are receiving or seeking medical care at the participating Proton Therapy Center will be invited to participate in the Research Registry.
Exclusion criteria
- Subjects who do not agree to participate
Treatment and study plan
Primary outcomes
-
Long-term follow-up
Time frame: 6 months
Maintaining regular, lifetime contact with subjects in order to obtain current identification , contact information, and self/parent-reported health status in order to obtain a better understanding of overall treatment strategies and patient benefits of treatment.
Secondary outcomes
-
Future Research Possibilities
Time frame: 12 months
Performing retrospective research studies on diseases treated with proton therapy throughout the United States.
Permitting review of medical record information contained within the Registry to identify subjects who may be eligible for participation in future research studies conducted at the Proton Therapy Institution where the participant was treated. Obtaining the permission of Research Registry participants to be contacted to ascertain their interest in participating in future research studies being conducted at their participating Proton Therapy Institution for which it appears (i.e., based on medical information contained within the Research Registry) they may be eligible.
Study contacts
Contact information is provided by the study sponsor or research team.
James R Gray, M.D.
CONTACT
Kristi Simcox, BS, CCRP
CONTACT
Sponsors and collaborators
Lead sponsor
Center for Biomedical Research, LLC
Other
Collaborators
- Provision Center for Proton Therapy
Registry information
Acronym: Registry
Important dates
- Study start
- 2013
- Primary completion
- 2050
- Study completion
- 2050
- First posted
- Feb 25, 2014
- Registry last updated
- Feb 8, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy
NCT07724535
Cancer, Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsYunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
NCT05754801
Cancer, Neoplasms
Hong Kong
View Trial DetailsImpact of Gonadotoxic Therapies on Fertility
NCT05885048
Cancer, Effects of Immunotherapy
Bern, Switzerland
View Trial DetailsRare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761
Cancer, Environment
Bethesda, Maryland, United States
View Trial Details